Focus: Osteal Therapeutics is a public-stage biotechnology company focused on drug-device combination therapies for prosthetic joint infection prevention in the musculoskeletal space. The company operates with a narrow therapeutic focus and early-stage pipeline.
Profile data last refreshed 3h ago · AI intelligence enriched 1mo ago
Growing — net +8 jobs in 30d
9 jobs added vs 1 removed. Steady team buildout.
Suitable only for risk-tolerant candidates seeking deep technical involvement in a niche musculoskeletal device-drug space, but limited growth signals and hiring activity warrant caution.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Osteal Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Osteal Therapeutics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles